What’s New in Photon Counting CT?

July 25, 2026 · 9 articles · 9 research themes · covering July 18, 2026 – July 25, 2026

Overview

Across this week’s papers, photon-counting CT (PCD/PCCT) emerges as a consistent theme: multiple studies compare it directly with energy-integrating CT (EID-CT), showing that spectral capabilities can improve diagnostic performance while reducing dose. In coronary CTA, evidence from a preregistered systematic review/meta-analysis suggests PCD-CT may better handle calcium-related artifacts (e.g., blooming) and improve stenosis reclassification—potentially lowering downstream unnecessary invasive angiography. Complementing this, phantom and reproducibility work focuses on coronary plaque quantification: PCD-CT with virtual monoenergetic reconstructions improves detectability of low-attenuation plaque, and careful selection of reconstruction kernels/iterative settings can reduce variability between platforms, supporting harmonized multi-scanner/multi-center trials.

Outside cardiology, the same hardware advantages translate to abdominal imaging and quantitative tissue assessment. Head-to-head abdominal studies report comparable or improved visualization of hepato-bilio-pancreatic anatomy with PCCT, while a prospective multi-phase abdominopelvic trial demonstrates substantial radiation dose reductions without sacrificing objective or subjective image quality. Spectral imaging is further leveraged for hepatic steatosis: 190-keV virtual monoenergetic imaging from contrast-enhanced acquisitions can serve as a practical surrogate for true non-contrast liver CT, potentially streamlining fatty liver workflows.

Finally, the digest broadens from detector physics to quantitative and integrated imaging paradigms. CT-based deformable registration and computational modeling can map regional lung mechanics in ARDS, capturing heterogeneity relevant to ventilator-induced lung injury risk. In parallel, a narrative review highlights AI-driven automation and multimodality integration as a route toward precision phenotyping in heart failure. For hematologic malignancies, a clinical review provides decision frameworks for choosing whole-body low-dose CT versus whole-body MRI, emphasizing scenario-specific tradeoffs such as radiation, availability, expertise, and cost.

---

Photon-Counting CT vs Energy-Integrating CT (Coronary CTA)

Comparison of Photon-Counting and Energy-Integrating Computed Coronary Tomography Angiography for Coronary Artery Disease: A Systematic Review and Meta-Analysis.

This preregistered systematic review and meta-analysis compared photon-counting detector CT (PCD-CT) with energy-integrating CT (EID-CT) for coronary CTA diagnostic outcomes in adults with stable coronary artery disease. The key finding was that PCD-CT’s spectral/spatial advantages can mitigate calcium blooming and improve stenosis reclassification/quantification, potentially reducing overestimation and downstream low-yield referrals to invasive coronary angiography. Clinically, this supports adopting PCD-CT to improve the accuracy of coronary CTA interpretation, which may enhance patient selection for invasive testing.

Kurugalage R, Bhatia A, Mukherjee A et al. · JACC. Cardiovascular imaging · (2026) · View on PubMed ↗ · Free PDF ↗

---

Photon-Counting CT vs Energy-Integrating CT (Abdominal/Hepatobiliary)

Photon-counting CT for hepato-bilio-pancreatic imaging: a qualitative head-to-head comparison with third-generation dual-source CT: preliminary results.

This retrospective head-to-head study compared photon-counting CT (PCCT) with third-generation dual-source energy-integrating CT (EID-CT) for qualitative image quality of hepato-bilio-pancreatic anatomy in the same cohort of 25 patients undergoing contrast-enhanced abdominal CT. The key finding was that PCCT provided comparable or improved reader-based visualization of abdominal structures/anatomical detail relative to EID-CT, despite differences in reconstructed section thickness (0.4–0.6 mm for PCCT vs 1.0 mm for EID-CT). This supports the potential of PCCT to enhance abdominal diagnostic imaging quality, which could translate into better lesion conspicuity and more confident interpretation in hepato-bilio-pancreatic assessment.

Foti G, Spoto F, Spezia A et al. · La Radiologia medica · (2026) · View on PubMed ↗

---

Photon-Counting CT Spectral Imaging for Tissue Characterization

Single-Phase Surrogate for True Non-Contrast Liver CT Using 190-keV Monoenergetic Imaging on Photon-Counting CT: Implications for Hepatic Steatosis Assessment.

This study evaluated whether 190-keV virtual monoenergetic imaging (VMI) from photon-counting detector CT (PCD-CT) can act as a surrogate for true non-contrast (TNC) liver CT for hepatic steatosis quantification, using 49 patients with abdominal PCD-CT and MRI-proton density fat fraction (PDFF) within 2 months. The key finding was that 190-keV VMI reconstructed from equilibrium-phase scans showed strong attenuation agreement with TNC (and was compared against virtual non-contrast, VNC), supporting its use as a practical non-contrast surrogate for steatosis-related measurements. Clinically, this could reduce the need for separate non-contrast scans in fatty liver assessment by leveraging spectral PCD-CT to generate non-contrast-like images from contrast-enhanced acquisitions.

Ohtani T, Shimada M, Nishiyama K et al. · Academic radiology · (2026) · View on PubMed ↗

---

Dose Efficiency and Image Quality in Photon-Counting CT

Photon-counting CT vs. energy-integrating detector CT: image quality and radiation dose in multi-phase abdominopelvic imaging.

This prospective study enrolled 94 adults to compare photon-counting CT (PCCT) versus energy-integrating CT (EID-CT) in multi-phase abdominopelvic imaging, assessing objective image quality (hepatic noise, SNR, CNR), subjective radiologist scores, and radiation dose metrics (CTDIvol, DLP, nDLP). The key finding was that PCCT significantly reduced radiation dose (CTDIvol by 57%, DLP by 62%, and nDLP by 57%) while maintaining or improving image quality measures. This is significant because it supports PCCT as a dose-efficient alternative to EID-CT for abdominopelvic CT protocols without sacrificing diagnostic image quality.

Huang YF, Yang JF, Zhao L et al. · Radiation protection dosimetry · (2026) · View on PubMed ↗

---

Reproducibility and Multi-Platform Harmonization (CT Plaque Metrics)

Coronary plaque quantification on energy-integrating and photon-counting detector CT: reproducibility and power modeling for mixed-platform trials.

The study assessed reproducibility of coronary plaque quantification between energy-integrating detector CT (EID-CT) and photon-counting detector CT (PCD-CT) and built power/sample-size models for mixed-platform trials using patients who underwent coronary CT angiography on both systems within 30 days. It found that plaque-component measurements (including low-attenuation plaque) varied less when specific reconstruction kernels and quantum iterative reconstruction strengths were used, and these variability estimates were used to model trial power requirements. This is clinically significant because it supports harmonizing plaque metrics across CT platforms, enabling multi-center/multi-scanner trials of coronary atherosclerosis therapies.

Vecsey-Nagy M, Hagar MT, Osoria-Velasquez J et al. · European radiology · (2026) · View on PubMed ↗

---

Coronary Plaque Composition and Low-Attenuation Plaque Detection

Mixed coronary plaque phantom analysis by photon-counting CT: impact of calcium and iodine on low-attenuation plaque detection.

The study evaluated photon-counting detector CT (PCD-CT) versus energy-integrating detector CT (EID-CT) for detecting low-attenuation plaque (LAP) using a custom mixed-coronary plaque phantom with iodinated lumen (600/1000 HU), calcified arcs (200/800 mg/cc), and a narrow LAP strip (~1–1.5 mm, 75 HU) embedded in fat-equivalent material (-60 HU). PCD-CT with virtual monoenergetic reconstructions (40–130 keV) and different kernels/quantum iterative settings showed improved LAP detectability relative to EID-CT, with calcium and iodine content influencing the optimal energy/kernel choice for LAP visibility. This phantom-based evidence supports using PCD-CT spectral imaging to better characterize coronary plaque composition, potentially improving coronary CTA risk stratification and reducing misclassification driven by calcium/iodine effects.

Szilveszter B, Kolossváry M, Kubovje A et al. · European heart journal. Imaging methods and practice · (2026) · View on PubMed ↗

---

Quantitative CT for Lung Mechanics in ARDS/VILI

Quantitative assessment of lung mechanical properties in ARDS using X-ray computed tomography.

This work studied how X-ray computed tomography (CT) combined with quantitative image processing, deformable image registration, and computational modeling can estimate regional lung mechanics (e.g., strain/recruitment and inferred mechanical stress) in patients with acute respiratory distress syndrome (ARDS). The key finding is that CT-based regional mechanical property mapping captures spatial heterogeneity that global physiologic measures miss, enabling more localized assessment relevant to ventilator-induced lung injury (VILI) risk. Scientifically, it advances CT as a quantitative tool for precision-guided ventilation by linking regional aeration/deformation to mechanical stress and recruitment estimates.

Gao J, Garberi R, Akor EA et al. · Intensive care medicine experimental · (2026) · View on PubMed ↗

---

AI-Enabled Integrated Cardiac Imaging and Precision Phenotyping

The Future of Imaging in Heart Failure: Toward Precision Phenotyping, Integration, and Intelligence.

This narrative review studied current and emerging cardiac imaging approaches for heart failure (HF) with the goal of moving from modality-siloed description toward precision phenotyping and integrated, intelligence-driven workflows. The key finding is that artificial intelligence (AI) is increasingly enabling automation of image acquisition/analysis (notably in echocardiography) and that integrating multimodality data can improve patient-specific prediction and treatment targeting. Scientifically and clinically, it frames how imaging can become a predictive, integrated system for HF subtyping and management rather than a purely descriptive diagnostic tool.

Hundertmark MJ · Current heart failure reports · (2026) · View on PubMed ↗ · Free PDF ↗

---

Whole-Body Imaging Strategy in Hematologic Malignancies (WBCT vs WBMRI)

Complementary Role of Whole-Body MRI and CT in Hematologic Malignancies and Bone Marrow Disorders.

This clinical review studied the complementary roles of whole-body MRI (WBMRI) and whole-body low-dose CT (WBCT) in hematologic malignancies and bone marrow disorders, focusing on practical decision-making across diagnosis, staging, response assessment, and surveillance. The key finding is that the choice between WBCT and WBMRI depends on scenario-specific factors such as scanner availability, expertise, patient tolerance, radiation considerations, and cost, with comparative evidence highlighted for multiple myeloma. This is significant because it provides an actionable framework to optimize imaging selection while balancing diagnostic performance and real-world constraints in hematology care.

Ghotbi E, Frick M, Cook J et al. · Journal of computer assisted tomography · (2026) · View on PubMed ↗

---

---

Generated automatically on July 25, 2026. Covers PubMed articles published July 18, 2026 – July 25, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.